HARVARD BIOSCIENCE INC
For the period ended Dec 31, 2025. Filed Mar 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 13, 2026
HBIO$9.26+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| HARVARD BIOSCIENCE, INC. | ||||||
|---|---|---|---|---|---|---|
| CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY | ||||||
| (In thousands) | ||||||
| Accumulated | ||||||
| Number · Additional · Other · Total | ||||||
| of Shares | Common | Paid-in | Accumulated | Comprehensive | Stockholders’ | |
| Issued | Stock | Capital | Deficit | Loss | Equity | |
| Balance at December 31, 2023 | 43,395 | $434 | $232,435 | $(145,605) | $(14,190) | $73,074 |
| Stock option exercises | 14 | - | 43 | - | - | 43 |
| Stock purchase plan | 161 | 2 | 335 | - | - | 337 |
| Vesting of restricted stock units | 769 | 8 | - | - | - | 8 |
| Shares withheld for taxes | (265) | (3) | (574) | - | - | (577) |
| Stock-based compensation | - | - | 4,340 | - | - | 4,340 |
| Net loss | - | - | - | (12,405) | - | (12,405) |
| Other comprehensive loss | - | - | - | - | (1,480) | (1,480) |
| Balance at December 31, 2024 | 44,074 | 441 | 236,579 | (158,010) | (15,670) | 63,340 |
| Stock purchase plan | 123 | 1 | 46 | - | - | 47 |
| Vesting of restricted stock units | 755 | 8 | - | - | - | 8 |
| Shares withheld for taxes | (233) | (3) | (153) | - | - | (156) |
| Stock-based compensation | - | - | 1,855 | - | - | 1,855 |
| Net loss | - | - | - | (56,700) | - | (56,700) |
| Other comprehensive income | - | - | - | - | 3,998 | 3,998 |
| Issuance of warrants | - | - | 1,342 | - | - | 1,342 |
| Balance at December 31, 2025 | 44,719 | $447 | $239,669 | $(214,710) | $(11,672) | $13,734 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.